Gast ::
| Hauptseite > Publikationsdatenbank > Dopamine metabolism of the nucleus accumbens and fronto-striatal connectivity modulate impulse control > print |
| Hauptseite > Publikationsdatenbank > Dopamine metabolism of the nucleus accumbens and fronto-striatal connectivity modulate impulse control > print |
| 001 | 860706 | ||
| 005 | 20210130000603.0 | ||
| 024 | 7 | _ | |a 10.1093/brain/awz007 |2 doi |
| 024 | 7 | _ | |a 0006-8950 |2 ISSN |
| 024 | 7 | _ | |a 1460-2156 |2 ISSN |
| 024 | 7 | _ | |a pmid:30753324 |2 pmid |
| 024 | 7 | _ | |a WOS:000512724900026 |2 WOS |
| 024 | 7 | _ | |a altmetric:55253088 |2 altmetric |
| 037 | _ | _ | |a FZJ-2019-01371 |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |0 P:(DE-HGF)0 |a Hammes, Jochen |b 0 |
| 245 | _ | _ | |a Dopamine metabolism of the nucleus accumbens and fronto-striatal connectivity modulate impulse control |
| 260 | _ | _ | |a Oxford |b Oxford Univ. Press |c 2019 |
| 336 | 7 | _ | |2 DRIVER |a article |
| 336 | 7 | _ | |2 DataCite |a Output Types/Journal article |
| 336 | 7 | _ | |0 PUB:(DE-HGF)16 |2 PUB:(DE-HGF) |a Journal Article |b journal |m journal |s 1551881232_1163 |
| 336 | 7 | _ | |2 BibTeX |a ARTICLE |
| 336 | 7 | _ | |2 ORCID |a JOURNAL_ARTICLE |
| 336 | 7 | _ | |0 0 |2 EndNote |a Journal Article |
| 520 | _ | _ | |a Impulsive-compulsive behaviours like pathological gambling or hypersexuality are a frequent side effect of dopamine replacement therapy in patients with Parkinson’s disease. Multiple imaging studies suggest a significant reduction of presynaptic dopamine transporters in the nucleus accumbens to be a predisposing factor, reflecting either a reduction of mesolimbic projections or, alternatively, a lower presynaptic dopamine transporter expression per se. Here, we aimed to test the hypothesis of fewer mesolimbic projections as a risk factor by using dopamine synthesis capacity as a proxy of dopaminergic terminal density. Furthermore, previous studies have demonstrated a reduction of fronto-striatal connectivity to be associated with increased risk of impulsive-compulsive behaviour in Parkinson’s disease. Therefore, another aim of this study was to investigate the relationship between severity of impulsive-compulsive behaviour, dopamine synthesis capacity and fronto-striatal connectivity. Eighty participants underwent resting state functional MRI and anatomical T1-weighted images [mean age: 68 ± 9.9 years, 67% male (patients)]. In 59 participants, 18F-DOPA-PET was obtained and voxel-wise Patlak slopes indicating dopamine synthesis capacity were calculated. All participants completed the QUIP-RS questionnaire, a well validated test to quantify severity of impulsive-compulsive behaviour in Parkinson’s disease. A voxel-wise correlation analysis between dopamine synthesis capacity and QUIP-RS score was calculated for striatal regions. To investigate the relationship between symptom severity and functional connectivity, voxel-wise correlations were performed. A negative correlation was found between dopamine synthesis capacity and QUIP-RS score in the nucleus accumbens (r = −0.57, P = 0.001), a region functionally connected to the rostral anterior cingulate cortex. The connectivity strength was modulated by QUIP-RS, i.e. patients with more severe impulsive-compulsive behaviours had a weaker functional connectivity between rostral anterior cingulate cortex and the nucleus accumbens. In addition, cortical thickness and severity of impulsive-compulsive behaviour were positively correlated in the subgenual rostral anterior cingulate cortex. We found three factors to be associated with severity of impulsive-compulsive behaviour: (i) decreased dopamine synthesis capacity in the nucleus accumbens; (ii) decreased functional connectivity of the rostral anterior cingulate cortex with the nucleus accumbens; and (iii) increased cortical thickness of the subgenual rostral anterior cingulate cortex. Rather than a downregulation of dopamine transporters, a reduction of mesolimbic dopaminergic projections in conjunction with a dysfunctional rostral anterior cingulate cortex—a region known to play a key role in impulse control—could be the most crucial neurobiological risk factor for the development of impulsive-compulsive behaviours in patients with Parkinson’s disease under dopamine replacement therapy. |
| 536 | _ | _ | |0 G:(DE-HGF)POF3-572 |a 572 - (Dys-)function and Plasticity (POF3-572) |c POF3-572 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Theis, Hendrik |b 1 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Giehl, Kathrin |b 2 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Hoenig, Merle C |b 3 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Greuel, Andrea |b 4 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Tittgemeyer, Marc |b 5 |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Timmermann, Lars |b 6 |
| 700 | 1 | _ | |0 P:(DE-Juel1)131720 |a Fink, Gereon Rudolf |b 7 |u fzj |
| 700 | 1 | _ | |0 P:(DE-Juel1)177611 |a Drzezga, Alexander |b 8 |u fzj |
| 700 | 1 | _ | |0 P:(DE-HGF)0 |a Eggers, Carsten |b 9 |
| 700 | 1 | _ | |0 P:(DE-Juel1)169110 |a van Eimeren, Thilo |b 10 |e Corresponding author |u fzj |
| 773 | _ | _ | |0 PERI:(DE-600)1474117-9 |a 10.1093/brain/awz007 |n 3 |p 733-743 |t Brain |v 142 |x 1460-2156 |y 2019 |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/860706/files/awz007.pdf |y Restricted |
| 856 | 4 | _ | |u https://juser.fz-juelich.de/record/860706/files/awz007.pdf?subformat=pdfa |x pdfa |y Restricted |
| 909 | C | O | |o oai:juser.fz-juelich.de:860706 |p VDB |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)131720 |a Forschungszentrum Jülich |b 7 |k FZJ |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)177611 |a Forschungszentrum Jülich |b 8 |k FZJ |
| 910 | 1 | _ | |0 I:(DE-588b)5008462-8 |6 P:(DE-Juel1)169110 |a Forschungszentrum Jülich |b 10 |k FZJ |
| 913 | 1 | _ | |0 G:(DE-HGF)POF3-572 |1 G:(DE-HGF)POF3-570 |2 G:(DE-HGF)POF3-500 |a DE-HGF |b Key Technologies |l Decoding the Human Brain |v (Dys-)function and Plasticity |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |
| 914 | 1 | _ | |y 2019 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0420 |2 StatID |a Nationallizenz |
| 915 | _ | _ | |0 StatID:(DE-HGF)0100 |2 StatID |a JCR |b BRAIN : 2017 |
| 915 | _ | _ | |0 StatID:(DE-HGF)0200 |2 StatID |a DBCoverage |b SCOPUS |
| 915 | _ | _ | |0 StatID:(DE-HGF)0300 |2 StatID |a DBCoverage |b Medline |
| 915 | _ | _ | |0 StatID:(DE-HGF)0310 |2 StatID |a DBCoverage |b NCBI Molecular Biology Database |
| 915 | _ | _ | |0 StatID:(DE-HGF)0320 |2 StatID |a DBCoverage |b PubMed Central |
| 915 | _ | _ | |0 StatID:(DE-HGF)0600 |2 StatID |a DBCoverage |b Ebsco Academic Search |
| 915 | _ | _ | |0 StatID:(DE-HGF)0030 |2 StatID |a Peer Review |b ASC |
| 915 | _ | _ | |0 StatID:(DE-HGF)0199 |2 StatID |a DBCoverage |b Clarivate Analytics Master Journal List |
| 915 | _ | _ | |0 StatID:(DE-HGF)0110 |2 StatID |a WoS |b Science Citation Index |
| 915 | _ | _ | |0 StatID:(DE-HGF)0150 |2 StatID |a DBCoverage |b Web of Science Core Collection |
| 915 | _ | _ | |0 StatID:(DE-HGF)0111 |2 StatID |a WoS |b Science Citation Index Expanded |
| 915 | _ | _ | |0 StatID:(DE-HGF)1110 |2 StatID |a DBCoverage |b Current Contents - Clinical Medicine |
| 915 | _ | _ | |0 StatID:(DE-HGF)1030 |2 StatID |a DBCoverage |b Current Contents - Life Sciences |
| 915 | _ | _ | |0 StatID:(DE-HGF)1050 |2 StatID |a DBCoverage |b BIOSIS Previews |
| 915 | _ | _ | |0 StatID:(DE-HGF)9910 |2 StatID |a IF >= 10 |b BRAIN : 2017 |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-3-20090406 |k INM-3 |l Kognitive Neurowissenschaften |x 0 |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-2-20090406 |k INM-2 |l Molekulare Organisation des Gehirns |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-Juel1)INM-3-20090406 |
| 980 | _ | _ | |a I:(DE-Juel1)INM-2-20090406 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|